This HTML5 document contains 54 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q83925424
rdf:type
wikibase:Item
schema:description
scientific article published on 01 July 2006 wetenschappelijk artikel im Juli 2006 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована в липні 2006 artículu científicu espublizáu en xunetu de 2006
p:P577
wds:Q83925424-6B29D9E6-2B82-4EE5-90EE-1F36E6D87540
wdt:P577
2006-07-01T00:00:00Z
p:P2093
wds:Q83925424-D31A4E54-1B07-46C8-89A7-04FEEA8F4634 wds:Q83925424-DC930E7D-BE55-4CD7-8D47-2904E5119B6D wds:Q83925424-248437E1-81AD-4262-9DB2-F58857A2E523 wds:Q83925424-88AA2143-EAC1-41EC-91CA-2812D1FF590D wds:Q83925424-A8262B25-E6F0-4830-99D6-38D90378532C wds:Q83925424-6B430BF0-1E72-480F-BED4-A687D7EA1EDF wds:Q83925424-71930CEB-29F5-4C30-B700-A4577A8AF4DE wds:Q83925424-B1D5E3BD-C46A-48B8-AC22-A05F15005367 wds:Q83925424-BF6EF100-5AEB-466A-9381-8C404FB4AD8E
wdt:P2093
James Montie William A See David G McLeod Donald Gleason Clive Morris Gerald Chodak Jonathon Armstrong Gregory Bernstein Ira Klimberg
rdfs:label
The bicalutamide 150 mg early prostate cancer program: findings of the North American trial at 7.7-year median followup The bicalutamide 150 mg early prostate cancer program: findings of the North American trial at 7.7-year median followup
skos:prefLabel
The bicalutamide 150 mg early prostate cancer program: findings of the North American trial at 7.7-year median followup The bicalutamide 150 mg early prostate cancer program: findings of the North American trial at 7.7-year median followup
schema:name
The bicalutamide 150 mg early prostate cancer program: findings of the North American trial at 7.7-year median followup The bicalutamide 150 mg early prostate cancer program: findings of the North American trial at 7.7-year median followup
p:P1476
wds:Q83925424-3AE0D48E-75C0-4019-83D1-59FF02CA5C13
wdt:P1476
The bicalutamide 150 mg early prostate cancer program: findings of the North American trial at 7.7-year median followup
p:P304
wds:Q83925424-2B2B74D3-3BEC-4FB1-8792-A982BBE3A1E3
wdt:P304
75-80
p:P31
wds:Q83925424-0077E401-DBCB-4FCC-B65B-59FB0F16DEB0
wdt:P31
wd:Q13442814
p:P921
wds:Q83925424-186F85FC-F35C-4173-9CAC-967E9A0AA01E wds:Q83925424-48392974-B9A1-4331-B256-CA12D04D8522
wdt:P921
wd:Q1988832 wd:Q181257
p:P698
wds:Q83925424-42531A2F-E55F-481B-8032-86929B80F9EF
wdtn:P698
n10:16753373
wdt:P698
16753373
p:P1433
wds:Q83925424-CB568174-C8A1-45A6-B3DA-3EB65876C8E6
wdt:P1433
wd:Q15709979
p:P433
wds:Q83925424-DE0B238B-8B0E-4843-B9E3-49EA018B0466
p:P478
wds:Q83925424-4C3364C1-80BD-495A-8973-9CFE51AAAC90
wdt:P433
1
wdt:P478
176
p:P356
wds:Q83925424-C2899037-BFC1-44B5-A9A1-8EE5FC829B91
wdtn:P356
n12:S0022-5347(06)00495-2
wdt:P356
10.1016/S0022-5347(06)00495-2